Creatine kinase is slow and non-specific. CellWise re-assays your athletes and computes the gene-expression deltas across the stress-profile domains like inflammatory load, metabolic efficiency, and recovery & repair demand, so you can see what actually shifted since the last screen and adjust training load with molecular evidence.
The decisions creatine kinase can't actually support.
CK is slow to respond and non-specific, which makes it weak for day-to-day load decisions. CellWise reads post-exercise transcriptomic change directly, resolved to the domains carrying the load.
Fatigue and overuse build before they surface. The stress profile breaks biological load into domains, from inflammatory load to recovery and repair demand, each traced to the genes driving it.
Progress is guesswork without a baseline. Longitudinal re-assays compute the gene-expression deltas since the last screen, so every cycle is measured, not estimated.
The clinical home base. Use-case assessments, immuno-metabolic phenotyping, the therapeutic target map, stress profiling, and more, all in one report.
The quantitative, visual view of the patient's raw biomarker data, shown as a population-vs-patient overview.
A filterable, gene-level interface over the patient's complete dataset, exposing the top cell populations carrying each signal.
Test a clinical hypothesis against the patient's own molecular data and re-run it in seconds.
Assay-independent surveillance across dosing phases, peptide-specific labs, and wearable trends, with no repeat sequence required.
Immune age, senescence, and the 12 hallmarks from one PBMC sample, for cell-resolved biological aging.
Re-assay a patient and see the gene-expression deltas across key biomarkers, so you see what has shifted since the last screen.
Where serum markers lag days behind, single-cell deltas show the mobilization and stress response as it resolves.
Seeing recovery-and-repair demand ease on the re-assay before CK normalized would let me step training back up a full cycle earlier.
A transcript-level delta between screens is exactly the daily-decision resolution serum markers have never given us.
For an athlete managing a chronic inflammatory issue, benchmarking the actual biological load each cycle changes how we periodize.